Document is current
Any future updates will be listed below
-
Authors
Chauchat, Laure https://orcid.org/0009-0004-3916-6478
Guerin, Camille
Rebika, Hayette
Sahyoun, Marwan
Collignon, Nathalie
-
Funding
Funding for this research was provided by:
Laboratoires Horus Pharma
- License Information
-
More Information
Article History
Received: 26 June 2024
Accepted: 25 July 2024
First Online: 12 August 2024
Declarations
:
: Laure Chauchat, Camille Guerin, Hayette Rebika and Marwan Sahyoun were employed by Horus Pharma Company. Nathalie Collignon have nothing to disclose.
: The study was approved for each of the 11 clinical sites by four correspondent ethics committees (C.H. Bois de l’Abbaye, Seraing, 21/02/2022, reference number 2022/02; Clinique Sainte-Elisabeth C.H.U. UCL Namur, Namur, 01/03/2022, reference number 05-22; C.H.U. de Liège, Liège, 01/04/2022, reference number 2022/34; and C.H.U. Saint-Pierre, Bruxelles, 07/04/2022, reference number CE/22-04-02) and was conducted in accordance with all applicable regulatory requirements and the Helsinki Declaration of 1964 and its later amendments (Version 64th, World Medical Association, Fortaleza, Brazil, 2013). The data used in this study were de-identified to ensure the confidentiality and anonymity of the participants. No information that could directly identify individuals was included in the datasets analysed.
